Profile
Bernd Schmidt is currently the Chief Technical Officer at Sensorion SA since 2023.
Prior to this, he worked as the Vice President-Product Delivery at Quell Therapeutics Ltd. Mr. Schmidt is a graduate of Friedrich-Alexander University of Erlangen-Nuremberg.
Bernd Schmidt active positions
| Companies | Position | Start |
|---|---|---|
| SENSORION | Chief Tech/Sci/R&D Officer | 2023-12-10 |
Former positions of Bernd Schmidt
| Companies | Position | End |
|---|---|---|
Quell Therapeutics Ltd.
Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops and supplies immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases | Corporate Officer/Principal | - |
Training of Bernd Schmidt
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Friedrich-Alexander University of Erlangen-Nuremberg
Friedrich-Alexander University of Erlangen-Nuremberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sensorion SA
Sensorion SA Pharmaceuticals: MajorHealth Technology Operates as a research and development company that discovers drugs to treat inner ear disorders | Health Technology |
Quell Therapeutics Ltd.
Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops and supplies immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Bernd Schmidt
















